AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Several cell survival signaling pathways in CML cells have been shown to be modulated by Bcr-Abl, including Jak/Stat, JNK, and PI3K/AKT/mTOR signaling pathways [3].